Literature DB >> 28680841

Hepatic Encephalopathy in Liver Cirrhosis.

Herbert Djiambou-Nganjeu1.   

Abstract

Liver cirrhosis is a worldwide gastroenterological condition, characterized by a slow, progressive and irreversible replacement of liver cells by fibrous tissue (scar) that prevents liver function. This condition often leads to the development of other syndromes. Cardiac complications can be indicated through abnormal QTc interval and arrhythmias, thereby their analysis aids in the prevention of cardiovascular events. Most cirrhotic cases have abnormal laboratory values (bilirubin, albumin, AST, ALT, AST/ALT, INR) indicating the presence of concomitant infection, inflammation and coagulopathy. In this case report, the usage Halstead-Reitan and Child-Pugh score helped in the assessment of the status of deterioration of brain. The knowledge of liver cirrhosis aetiologies help to determine the predisposition to development of hepatic encephalopathy and cardiomyopathy. The different values of liver enzymes and other blood laboratory analyses indicated the level of liver damage and poor prognosis.

Entities:  

Keywords:  Child-Pugh score; QTc interval; alcoholic liver cirrhosis; hepatic encephalopathy; liver cirrhosis; viral liver cirrhosis

Year:  2017        PMID: 28680841      PMCID: PMC5490964          DOI: 10.1515/jtim-2017-0013

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


  8 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

Review 2.  Hepatic encephalopathy: suspect it early in patients with cirrhosis.

Authors:  Jamilé Wakim-Fleming
Journal:  Cleve Clin J Med       Date:  2011-09       Impact factor: 2.321

Review 3.  The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.

Authors:  Yasuko Iwakiri; Roberto J Groszmann
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

Review 5.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis.

Authors:  Qin Wu; Lijun Shen; Jindong Chu; Xuemei Ma; Bo Jin; Fanping Meng; Jinpin Chen; Yanling Wang; Libing Wu; Jun Han; Wenhui Zhang; Wei Ma; Huaming Wang; Hanwei Li
Journal:  Oncol Lett       Date:  2014-10-22       Impact factor: 2.967

7.  A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy.

Authors:  Qiu-Ming Wang; Qing Ji; Zhi-Jun Duan; Ming Zhang; Qing-Yong Chang
Journal:  Exp Ther Med       Date:  2013-06-03       Impact factor: 2.447

Review 8.  Hepatic encephalopathy--a serious complication of alcoholic liver disease.

Authors:  Roger F Butterworth
Journal:  Alcohol Res Health       Date:  2003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.